emeis Société anonyme (EMEIS) Fair Value & Analysis

Healthcare · FR · Market cap €2.3B

Below-average quality, screening 101% undervalued on our models.

What matters now

• The large discount to fair value meets weak quality (37/100). That raises the risk this is a value trap rather than a bargain.
• The model range is unusually wide (€8.63 to €29.05). The outcome hinges heavily on assumptions, so read the point estimate with caution.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.

How to read this chart

60‑month range €4.79 – €7,041 · fair‑value band €8.63 – €29.05 · the €14.47 price screens below the €29.05 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

emeis Société anonyme (EMEIS) currently trades at €14.47, while our model-based Fair Value estimate is €29.05, implying the stock looks roughly 100.8% undervalued today. The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, emeis Société anonyme generated revenue of €5.9B at a net margin of -5.1%. Revenue grew 4.3% year over year. It earns a return on equity of -19.1%. Net debt stands at €8.3B. Fundamentals as of Jul 16, 2026

Our scenario range runs from €8.63 (bear case) to €29.05 (bull case); at €14.47, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 11% below its 52-week high and 46% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 101%, EMEIS screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: DCF Models (€28.72) versus Growth DCF (€3.50). Highest evidence: Growth DCF (80).

Key figures & financial health

Quality Score breakdown

About the company

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.

Full company description

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its services include concierge, housekeeping, ironing, internet connection, TV, telephone, free shuttles, catering and event organization, access to common areas, logistics support, DIY and gardening assistance, IT support, beauty and relaxation treatments, furniture on rent, fitness and wellness areas, and medical visits. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, schizophrenic disorders, autism spectrum disorders, psychotraumatic disorders, neurodegenerative diseases, Perinatal psychiatry, and burn-out. It operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the United Kingdom, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. The company was founded in 1989 and is headquartered in Puteaux, France.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

emeis Société anonyme reported revenue of €5.9B in FY2025 versus €4.3B in FY2021, a compound +8.2%/yr. Reported net income was −€298M in FY2025.

Watch EMEIS: get an alert when its fair value changes →

Peer Group

Medical Care Facilities · 262 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.